PK
Paawan Kirankumar Dubal
About Paawan Kirankumar Dubal
Data last updated:
Paawan Kirankumar Dubal is a Director at Cytoskinn Pharma Private Limited (since 2024). The company operates in Pharma. Cytoskinn Pharma Private Limited reported revenue of ₹2.56 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cytoskinn Pharma Private Limited U46102GJ2024PTC153239 | Director | 08 Jul 2024 | 2024 | ₹2.56 Cr (FY 2025) | Active |
Board colleagues of Paawan Kirankumar Dubal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kaushik Girdharbhai Bhanderi | 08876442 | Cytoskinn Pharma Private Limited | Director |
| Kirankumar Harshadrai Dubal | 02484432 | Cytoskinn Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Paawan Kirankumar Dubal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paawan Kirankumar Dubal
Paawan Kirankumar Dubal currently holds 1 directorship: Cytoskinn Pharma Private Limited (Director, since 08 Jul 2024, revenue ₹2.56 Cr (FY 2025)).
Paawan Kirankumar Dubal was first appointed on 08 Jul 2024 as Director at Cytoskinn Pharma Private Limited.
The current boards of Paawan Kirankumar Dubal's companies include Kaushik Girdharbhai Bhanderi (Cytoskinn Pharma Private Limited), Kirankumar Harshadrai Dubal (Cytoskinn Pharma Private Limited).